| Dr. Jose Jacob Scholarship for Future Doctors Opens Nationwide: A Timely Opportunity to Inspire Medical Students to Address Real-World Healthcare Challenges |
OCALA, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- The Dr. Jose Jacob Scholarship for Future Doctors is now officially open for applications, offering a one-time award of $1,000 to undergraduate students across the United States who are committed to pursuing a career in medicine. |
globenewswire.com |
2025-05-07 21:20:00 |
Czytaj oryginał (ang.) |
| All You Need to Know About Inspire (INSP) Rating Upgrade to Buy |
Inspire (INSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). |
zacks.com |
2025-05-07 17:00:56 |
Czytaj oryginał (ang.) |
| Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know |
The consensus price target hints at a 39% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
zacks.com |
2025-05-07 15:00:56 |
Czytaj oryginał (ang.) |
| INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts |
Inspire Medical's first-quarter 2025 performance reflects increased market penetration in existing centers and expansion into new territories and centers, along with strong domestic results. |
zacks.com |
2025-05-06 17:30:38 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. (INSP) Q1 2025 Earnings Call Transcript |
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2025 Results Conference Call May 5, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Kallum Titchmarsh - Morgan Stanley David Rescott - Baird Michael Sarcone - Jefferies Shagun Singh - RBC Chris Pasquale - Nephron Research Larry Biegelsen - Wells Fargo Anthony Petrone - Mizuho Financial Group Jon Block - Stifel Brett Fishbin - KeyBanc Capital Markets Michael Polark - Wolfe Research Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPM Adam Maeder - Piper Sandler Richard Newitter - Truist Operator Good afternoon. My name is Dilem and I'll be your conference operator today. |
seekingalpha.com |
2025-05-05 22:54:06 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems (INSP) Surpasses Q1 Earnings and Revenue Estimates |
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.23 per share. This compares to loss of $0.34 per share a year ago. |
zacks.com |
2025-05-05 22:10:33 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook |
Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter |
globenewswire.com |
2025-05-05 20:02:00 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference |
MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Inspire is scheduled to present at 2:20 p.m. |
globenewswire.com |
2025-04-29 12:00:00 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D. |
MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that two leading physicians in the field of sleep medicine and sleep surgery, Paul T. Hoff, M.D., M.S., an otolaryngologist, and Ruchir P. Patel, M.D., F.A.C.P., a sleep medicine specialist, will join Inspire in Vice President, Senior Medical Director roles, effective April 21 and June 2 respectively. |
globenewswire.com |
2025-04-21 12:00:00 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025 |
MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2025 after the close of trading on Monday, May 5. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. |
globenewswire.com |
2025-04-01 12:00:00 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum |
MINNEAPOLIS, March 06, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 18, 2025. |
globenewswire.com |
2025-03-06 10:00:00 |
Czytaj oryginał (ang.) |
| Here's Why Inspire Medical Systems (INSP) is a Strong Momentum Stock |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2025-02-25 12:50:45 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm |
PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire Medical”) on behalf of the company's long-term shareholders. |
globenewswire.com |
2025-02-17 10:30:00 |
Czytaj oryginał (ang.) |
| How Much Upside is Left in Inspire (INSP)? Wall Street Analysts Think 25.88% |
The consensus price target hints at a 25.9% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
zacks.com |
2025-02-13 12:56:12 |
Czytaj oryginał (ang.) |
| INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin Contracts |
Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the fourth quarter. |
zacks.com |
2025-02-11 14:25:20 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript |
Inspire Medical Systems, Inc. (NYSE:INSP ) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPMorgan Chris Pasquale - Nephron Research Anthony Petrone - Mizuho Financial Group Richard Newitter - Truist Securities David Rescott - Baird Adam Maeder - Piper Sandler Larry Biegelsen - Wells Fargo Shagun Singh - RBC Capital Markets Brett Fishbin - KeyBanc Capital Markets Jon Block - Stifel Michael Polark - Wolfe Research Mike Kratky - Leerink Partners Suraj Kalia - Oppenheimer & Co. Operator Good afternoon. My name is Dilem [ph] and I'll be your conference operator today. |
seekingalpha.com |
2025-02-11 01:55:01 |
Czytaj oryginał (ang.) |
| Inspire Medical's Earnings Surge in Q4 |
Inspire Medical Systems (INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) came in at $1.15, well ahead of the $0.73 consensus estimate. |
fool.com |
2025-02-10 20:46:03 |
Czytaj oryginał (ang.) |
| Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say |
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-02-10 20:31:07 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems (INSP) Q4 Earnings and Revenues Surpass Estimates |
Inspire Medical Systems (INSP) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.49 per share a year ago. |
zacks.com |
2025-02-10 20:11:09 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook |
Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 |
globenewswire.com |
2025-02-10 18:02:00 |
Czytaj oryginał (ang.) |
| Countdown to Inspire (INSP) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS |
Beyond analysts' top -and-bottom-line estimates for Inspire (INSP), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024. |
zacks.com |
2025-02-05 12:21:35 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems (INSP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release |
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-02-03 13:00:32 |
Czytaj oryginał (ang.) |
| Why Investors Need to Take Advantage of These 2 Medical Stocks Now |
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates. |
zacks.com |
2025-02-03 11:51:37 |
Czytaj oryginał (ang.) |
| These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar |
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP. |
zacks.com |
2025-01-21 11:56:09 |
Czytaj oryginał (ang.) |
| Inspire Medical Stock Falls Despite Solid Preliminary Q4 Revenues |
INSP's revenue growth in the fourth quarter is likely to have been boosted by increased market penetration in existing centers and expansion into new implanting centers. |
zacks.com |
2025-01-14 14:46:11 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2024 and Provides Initial 2025 Revenue Guidance |
Inspire Reports Year-over-Year Revenue Growth of 25% for the Fourth Quarter and 28% for the Full Year 2024 Inspire Reports Year-over-Year Revenue Growth of 25% for the Fourth Quarter and 28% for the Full Year 2024 |
globenewswire.com |
2025-01-13 08:45:00 |
Czytaj oryginał (ang.) |
| Why Inspire Medical Systems (INSP) is a Top Momentum Stock for the Long-Term |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2025-01-07 13:06:24 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference |
MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. |
globenewswire.com |
2024-12-30 10:00:00 |
Czytaj oryginał (ang.) |
| Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound |
Shares of ResMed (RMD) and Inspire Medical Systems (INSP) fell Monday as the companies behind products to treat sleep apnea faced a new threat from weight-loss drugs. |
investopedia.com |
2024-12-23 16:59:31 |
Czytaj oryginał (ang.) |
| Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors |
SAN MATEO, Calif.--(BUSINESS WIRE)-- #backpain--Presidio Medical, Inc., a clinical stage company developing a transformational neuromodulation platform, is pleased to announce Richard J. Buchholz will join its Board of Directors. Rick is the Chief Financial Officer of Inspire Medical Systems, Inc. (NYSE: INSP), where he has played a pivotal role in driving strategic financial and operational growth for the global leader in the development and commercialization of innovative, minimally invasive solutions fo. |
businesswire.com |
2024-12-05 14:12:00 |
Czytaj oryginał (ang.) |
| 5 Growth Stocks to Buy in December for Impressive Short-Term Upside |
These five growth stocks have strong potential for December. These are: MNDY, PSN, PI, INSP, INGR. |
zacks.com |
2024-12-04 11:01:34 |
Czytaj oryginał (ang.) |
| 5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025 |
Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV. |
zacks.com |
2024-12-04 11:01:30 |
Czytaj oryginał (ang.) |
| Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade |
BofA Securities has upgraded Inspire Medical Systems, Inc. INSP and says the company now falls in the profitable growth category. |
benzinga.com |
2024-11-20 16:08:22 |
Czytaj oryginał (ang.) |
| UPDATED – Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference |
MINNEAPOLIS, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. |
globenewswire.com |
2024-11-15 10:00:00 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program |
MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced that it entered into an accelerated share repurchase (“ASR”) transaction under an agreement with Goldman Sachs & Co. LLC, to repurchase an aggregate of $75.0 million of shares of the Company's common stock, par value $0.001 per share. The ASR transaction is being completed pursuant to a previously announced $150.0 million share repurchase program authorized by the Company's Board of Directors. |
globenewswire.com |
2024-11-11 08:45:00 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference |
MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. |
globenewswire.com |
2024-11-06 10:00:00 |
Czytaj oryginał (ang.) |
| INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts |
Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the third quarter. |
zacks.com |
2024-11-05 12:56:23 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. (INSP) Q3 2024 Earnings Call Transcript |
Inspire Medical Systems, Inc. (NYSE:INSP ) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ET Company Participants Ezgi Yagci – Vice President-Investor Relations Tim Herbert – President and Chief Executive Officer Rick Buchholz – Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Danielle Antalffy – UBS Travis Steed – Bank of America Securities Adam Maeder – Piper Sandler David Rescott – Baird Michael Sarcone – Jefferies Richard Newitter – Truist Securities Larry Biegelsen – Wells Fargo Shagun Singh – RBC Kallum Titchmarsh – Morgan Stanley Jon Block – Stifel Anthony Petrone – Mizuho Americas Brett Fishbin – KeyBanc Capital Markets Chris Pasquale – Nephron Research Michael Polark – Wolfe Research Mike Kratky – Leerink Partners Suraj Kalia – Oppenheimer & Co Operator Good afternoon. My name is Dilem, and I'll be your conference operator today. |
seekingalpha.com |
2024-11-04 23:12:31 |
Czytaj oryginał (ang.) |
| Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings |
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2024-11-04 21:36:21 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems (INSP) Q3 Earnings and Revenues Surpass Estimates |
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.29 per share a year ago. |
zacks.com |
2024-11-04 20:20:16 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. Announces Third Quarter 2024 Financial Results and Updates 2024 Outlook |
Inspire Reports Year-over-Year Revenue Growth of 33% and Earnings per Share of $0.60 in the Third Quarter Inspire Reports Year-over-Year Revenue Growth of 33% and Earnings per Share of $0.60 in the Third Quarter |
globenewswire.com |
2024-11-04 18:02:00 |
Czytaj oryginał (ang.) |
| Seeking Clues to Inspire (INSP) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics |
Evaluate the expected performance of Inspire (INSP) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. |
zacks.com |
2024-10-30 12:20:39 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference |
MINNEAPOLIS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. |
globenewswire.com |
2024-10-30 10:00:00 |
Czytaj oryginał (ang.) |
| Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell |
Medical Systems, 10x Genomics and Omnicell have been highlighted in this Industry Outlook article. |
zacks.com |
2024-10-29 07:05:21 |
Czytaj oryginał (ang.) |
| 3 Medical Info Systems Stocks to Gain From Healthcare Digitization |
Zacks Medical Info Systems industry stocks like Inspire Medical Systems, 10x Genomics and Omnicell are expected to gain from the GenAI wave. |
zacks.com |
2024-10-28 15:26:08 |
Czytaj oryginał (ang.) |
| Inspire (INSP) Upgraded to Buy: What Does It Mean for the Stock? |
Inspire (INSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
zacks.com |
2024-10-18 17:00:33 |
Czytaj oryginał (ang.) |
| Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024 |
MINNEAPOLIS, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2024 after the close of trading on Monday, November 4. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. |
globenewswire.com |
2024-10-07 12:00:00 |
Czytaj oryginał (ang.) |